Red Queen Bio develops AI-powered biological defenses, using proprietary datasets and models to design medical countermeasures that can keep pace with advancing AI capabilities. A public benefit corporation spun out of HelixNano, it was co-founded by Nikolai Eroshenko (CEO) and Hannu Rajaniemi (Executive Director). Its approach combines frontier AI models, lab automation, reinforcement learning and on-demand biologics manufacturing. The company launched with a $15 million seed round led by OpenAI, with participation from Cerberus Ventures, Fifty Years and Halcyon Futures.
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.